The Lord of the NanoRings: cyclodextrins and the battle against SARSCoV-2
Making a comparison between CDs and the unique Ring of the legendary novel of The Lord of the Rings, J.
Category: Drug delivery
Cyclodextrin as a magic switch in covalent and non-covalent anticancer drug release systems
This article reviews the controlled release of current anticancer drugs based on cyclodextrins as a “flexible switch”, and discusses the
Investigation of Cytotoxicity and Cell Uptake of Cationic Beta-Cyclodextrins as Valid Tools in Nasal Delivery
Cyclodextrin polymers have high applicability in pharmaceutical formulations due to better biocompatibility, solubility enhancement, loading capacity and controlled drug release
European Commission secures EU access to Remdesivir for treatment of COVID-19
The European Commission has signed a contract with the pharmaceutical company Gilead to secure treatment doses of Veklury, the brand
Oculis Successful End-Of-Phase 2 Meeting With The FDA, On Towards Phase 3
Oculis, the Icelandic-Swiss clinical stage boipharmaceutical company recently announced that they are progressing towards Phase 3 with OCS-01 in two
Ototoxicity of cyclodextrin derivatives
There are two possible mechanisms behind the ototoxicity of 2-hydroxypropyl-β-cyclodextrin (HPBCD) treatment. One is : the possible interaction of HPBCD
CD‐sACE2 complexes against Covid-19
Cyclodextrin‐soluble angiotensin‐converting enzyme 2 (CD‐sACE2) inclusion compounds can be useful in the treatment of SARS‐CoV‐2 infections by blocking S‐proteins .
Book: Advances and Avenues in the Development of Novel Carriers for Bioactives and Biological Agents
Advances and Avenues in the Development of Novel Carriers for Bioactives and Biological Agents provides sound data on the utility of
Veklury (remdesivir) becomes the first approved drug for the treatment of COVID-19 in the European Union
On the 3rd of July we arrived to another milestone in the fight against the novel coronavirus infection. Eurpean Comission
Repurpusing Famotidine against COVID-19: a Hope or a Hype?
Clinicians and scientists have been studying a number of old existing drugs with the hope of finding therapies they can